We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)
We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)
Safety Study of RMJH-111b to Treat Essential Hypertension
Updated: 7/13/2016
A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Tolerability of RMJH-111b in Adult Subjects With Essential Hypertension
Status: Enrolling
Updated: 7/13/2016
Safety Study of RMJH-111b to Treat Essential Hypertension
Updated: 7/13/2016
A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Tolerability of RMJH-111b in Adult Subjects With Essential Hypertension
Status: Enrolling
Updated: 7/13/2016
Click here to add this to my saved trials
Online CBT-I for High Blood Pressure
Updated: 7/14/2016
Online CBT-I for High Blood Pressure
Status: Enrolling
Updated: 7/14/2016
Online CBT-I for High Blood Pressure
Updated: 7/14/2016
Online CBT-I for High Blood Pressure
Status: Enrolling
Updated: 7/14/2016
Click here to add this to my saved trials
Dialysate Sodium Individualization in Hemodialysis
Updated: 7/21/2016
Hemodynamic and Hormonal Responses to Dialysate Sodium Individualization in Hemodialysis Patients
Status: Enrolling
Updated: 7/21/2016
Dialysate Sodium Individualization in Hemodialysis
Updated: 7/21/2016
Hemodynamic and Hormonal Responses to Dialysate Sodium Individualization in Hemodialysis Patients
Status: Enrolling
Updated: 7/21/2016
Click here to add this to my saved trials
An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Patients With Exercise Induced Pulmonary Arterial Hypertension
Updated: 7/27/2016
An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Patients With Exercise Induced Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 7/27/2016
An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Patients With Exercise Induced Pulmonary Arterial Hypertension
Updated: 7/27/2016
An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Patients With Exercise Induced Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 7/27/2016
Click here to add this to my saved trials
L-Arginine, Vascular Response and Mechanisms
Updated: 7/27/2016
L-Arginine, Vascular Response and Mechanisms
Status: Enrolling
Updated: 7/27/2016
L-Arginine, Vascular Response and Mechanisms
Updated: 7/27/2016
L-Arginine, Vascular Response and Mechanisms
Status: Enrolling
Updated: 7/27/2016
Click here to add this to my saved trials
Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
Updated: 7/28/2016
Sildenafil Treatment in Patients With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension - a Pilot Cross-over Study
Status: Enrolling
Updated: 7/28/2016
Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
Updated: 7/28/2016
Sildenafil Treatment in Patients With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension - a Pilot Cross-over Study
Status: Enrolling
Updated: 7/28/2016
Click here to add this to my saved trials
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
Updated: 8/1/2016
An Adaptive, Multi-center, Randomized, Investigator-masked, Subject-masked, Multiple-dose, Placebo-controlled, Parallel Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of RO5093151 for up to 28 Days in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension.
Status: Enrolling
Updated: 8/1/2016
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
Updated: 8/1/2016
An Adaptive, Multi-center, Randomized, Investigator-masked, Subject-masked, Multiple-dose, Placebo-controlled, Parallel Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of RO5093151 for up to 28 Days in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension.
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
Updated: 8/1/2016
An Adaptive, Multi-center, Randomized, Investigator-masked, Subject-masked, Multiple-dose, Placebo-controlled, Parallel Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of RO5093151 for up to 28 Days in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension.
Status: Enrolling
Updated: 8/1/2016
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
Updated: 8/1/2016
An Adaptive, Multi-center, Randomized, Investigator-masked, Subject-masked, Multiple-dose, Placebo-controlled, Parallel Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of RO5093151 for up to 28 Days in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension.
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
Updated: 8/1/2016
An Adaptive, Multi-center, Randomized, Investigator-masked, Subject-masked, Multiple-dose, Placebo-controlled, Parallel Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of RO5093151 for up to 28 Days in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension.
Status: Enrolling
Updated: 8/1/2016
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
Updated: 8/1/2016
An Adaptive, Multi-center, Randomized, Investigator-masked, Subject-masked, Multiple-dose, Placebo-controlled, Parallel Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of RO5093151 for up to 28 Days in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension.
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
Updated: 8/1/2016
An Adaptive, Multi-center, Randomized, Investigator-masked, Subject-masked, Multiple-dose, Placebo-controlled, Parallel Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of RO5093151 for up to 28 Days in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension.
Status: Enrolling
Updated: 8/1/2016
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
Updated: 8/1/2016
An Adaptive, Multi-center, Randomized, Investigator-masked, Subject-masked, Multiple-dose, Placebo-controlled, Parallel Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of RO5093151 for up to 28 Days in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension.
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Comparative Effectiveness of Ambulatory Blood Pressure Monitoring vs Usual Care for Diagnosing and Managing Hypertension: A Pilot Study
Updated: 8/8/2016
Comparative Effectiveness of Ambulatory Blood Pressure Monitoring vs Usual Care for Diagnosing and Managing Hypertension: A Pilot Study
Status: Enrolling
Updated: 8/8/2016
Comparative Effectiveness of Ambulatory Blood Pressure Monitoring vs Usual Care for Diagnosing and Managing Hypertension: A Pilot Study
Updated: 8/8/2016
Comparative Effectiveness of Ambulatory Blood Pressure Monitoring vs Usual Care for Diagnosing and Managing Hypertension: A Pilot Study
Status: Enrolling
Updated: 8/8/2016
Click here to add this to my saved trials
Evaluating CVD Medication Adherence Program in Low SES
Updated: 8/11/2016
Evaluating CVD Medication Adherence Program in Low SES
Status: Enrolling
Updated: 8/11/2016
Evaluating CVD Medication Adherence Program in Low SES
Updated: 8/11/2016
Evaluating CVD Medication Adherence Program in Low SES
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Updated: 8/15/2016
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Status: Enrolling
Updated: 8/15/2016
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Updated: 8/15/2016
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Status: Enrolling
Updated: 8/15/2016
Click here to add this to my saved trials
Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension
Updated: 11/17/2016
A Multiple-Dose Study of the IOP-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% When Added to a PGA as Adjunctive Therapy Over a 24 Hour Period in Patients With Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/17/2016
Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension
Updated: 11/17/2016
A Multiple-Dose Study of the IOP-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% When Added to a PGA as Adjunctive Therapy Over a 24 Hour Period in Patients With Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/17/2016
Click here to add this to my saved trials
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/17/2016
Updated: 11/17/2016
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/17/2016
Updated: 11/17/2016
Click here to add this to my saved trials
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Updated: 11/17/2016
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/17/2016
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Updated: 11/17/2016
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/17/2016
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Updated: 11/21/2016
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension
Updated: 12/13/2016
A Prospective, Multicenter, Randomized, Double-Masked, Parallel-Arm Phase 2b Study Evaluating the Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/13/2016
Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension
Updated: 12/13/2016
A Prospective, Multicenter, Randomized, Double-Masked, Parallel-Arm Phase 2b Study Evaluating the Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/13/2016
Click here to add this to my saved trials
The Effects of Strawberries on Blood Pressure in Postmenopausal Women
Updated: 12/15/2016
Daily Incorporation of Strawberries Into a Diet Favorably Improves Vascular Function and Lowers Aortic Blood Pressure in Postmenopausal Women With Prehypertension
Status: Enrolling
Updated: 12/15/2016
The Effects of Strawberries on Blood Pressure in Postmenopausal Women
Updated: 12/15/2016
Daily Incorporation of Strawberries Into a Diet Favorably Improves Vascular Function and Lowers Aortic Blood Pressure in Postmenopausal Women With Prehypertension
Status: Enrolling
Updated: 12/15/2016
Click here to add this to my saved trials
Endothelial Microparticles in Systemic Sclerosis Pulmonary Hypertension
Updated: 12/15/2016
Endothelial Mircroparticles as a Biomarker of Pulmonary Hypertension in Systemic Sclerosis
Status: Enrolling
Updated: 12/15/2016
Endothelial Microparticles in Systemic Sclerosis Pulmonary Hypertension
Updated: 12/15/2016
Endothelial Mircroparticles as a Biomarker of Pulmonary Hypertension in Systemic Sclerosis
Status: Enrolling
Updated: 12/15/2016
Click here to add this to my saved trials
Pathophysiology of Cardiometabolic Risk Factors in African Americans
Updated: 12/29/2016
Obesity, Hypertension in African American Women, Neuro-metabolic Mechanism
Status: Enrolling
Updated: 12/29/2016
Pathophysiology of Cardiometabolic Risk Factors in African Americans
Updated: 12/29/2016
Obesity, Hypertension in African American Women, Neuro-metabolic Mechanism
Status: Enrolling
Updated: 12/29/2016
Click here to add this to my saved trials
Cardiac Function as Measured by Non-invasive Electrical Velocimetry Cardiac Monitor in Hospitalized Children
Updated: 1/4/2017
A Pilot Study: Cardiac Function as Measured by Non-invasive Electrical Velocimetry Cardiac Monitor in Hospitalized Children From Acute Illness (Disease) to Recovery (Health).
Status: Enrolling
Updated: 1/4/2017
Cardiac Function as Measured by Non-invasive Electrical Velocimetry Cardiac Monitor in Hospitalized Children
Updated: 1/4/2017
A Pilot Study: Cardiac Function as Measured by Non-invasive Electrical Velocimetry Cardiac Monitor in Hospitalized Children From Acute Illness (Disease) to Recovery (Health).
Status: Enrolling
Updated: 1/4/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Updated: 1/9/2017
A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status: Enrolling
Updated: 1/9/2017
Click here to add this to my saved trials
Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial
Updated: 1/12/2017
Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial (LAMPET)
Status: Enrolling
Updated: 1/12/2017
Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial
Updated: 1/12/2017
Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial (LAMPET)
Status: Enrolling
Updated: 1/12/2017
Click here to add this to my saved trials
Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial
Updated: 1/12/2017
Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial (LAMPET)
Status: Enrolling
Updated: 1/12/2017
Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial
Updated: 1/12/2017
Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial (LAMPET)
Status: Enrolling
Updated: 1/12/2017
Click here to add this to my saved trials
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
Updated: 1/16/2017
A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria
Status: Enrolling
Updated: 1/16/2017
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
Updated: 1/16/2017
A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria
Status: Enrolling
Updated: 1/16/2017
Click here to add this to my saved trials
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
Updated: 1/16/2017
A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria
Status: Enrolling
Updated: 1/16/2017
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
Updated: 1/16/2017
A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria
Status: Enrolling
Updated: 1/16/2017
Click here to add this to my saved trials